Cognitive impairment in patients with Parkinson's disease: A 30-month follow-up study

Clinical Neurology and Neurosurgery

Volumn 151, Issue , 2016, Pages 65-69

  Chen, Ling ^a   Yu, Cuiyu ^b   Zhang, Ning ^b   Liu, Junjun ^c   Liu, Weiguo ^b  

^a Jiangsu Province Institute of Geriatrics   (China)

^b THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Department of Oncology   (China)

Author keywords

Cognitive impairment; Follow up; Mini mental state examination; Montreal cognitive assessment (MoCA); Parkinson's disease

Indexed keywords

CITICOLINE;

ADULT; AGED; ARTICLE; BODY POSTURE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GAIT DISORDER; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NONPARAMETRIC TEST; ORIENTATION; PARKINSON DISEASE; RECALL; RISK FACTOR; STUDENT T TEST; TREMOR; COGNITIVE DYSFUNCTION; COMPLICATION; DISEASE COURSE; PATHOPHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84993960778     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2016.09.021     Document Type: Article

References (30)

1. [1] Pagonabarraga, J., Kulisevsky, J., Cognitive impairment and dementia in Parkinson's disease. Neurobiol. Dis. 46:3 (2012), 590–596.
2. [2] Winter, Y., von Campenhausen, S., Arend, M., et al. Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study. Parkinsonism Relat. Disord. 17 (2011), 265–269.
3. [3] Aarsland, D., Andersen, K., Larsen, J.P., Lolk, A., Nielsen, H., Kragh-Sorensen, P., Risk of dementia in Parkinson's disease—a community-based, prospective study. Neurology 56 (2001), 730–736.
4. [4] Adler, C., Nonmotor complications in Parkinson's disease. Mov. Disord. 20:Suppl 11 (2005), 23–29 (H).
5. [5] Levy, G., Jacobs, D.M., Tang, M.X., Côté, L.J., Louis, E.D., Alfaro, B., et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov. Disord. 17:6 (2002), 1221–1226.
6. [6] Chen, Ling, Yu, Cuiyu, Fu, Xiaosu, Liu, Weiguo, Hua, Ping, Zhang, Ning, Guo, Shenghan, Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's disease. Shanghai Arch. Psychiatry 25:5 (2013), 296–304.
7. [7] Hu, M., Cooper, J., Beamish, R., et al. How well do we recognize non-motor symptoms in a British Parkinson's disease population. J. Neurol. 258 (2011), 1513–1517.
8. [8] Foltynie, T., Brayne, C.E., Robbins, T.W., Barker, R.A., The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127 (2004), 550–560.
9. [9] Zadikoff, C., Fox, S.H., Tang-Wai, D.F., et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov. Disord. 23 (2008), 297–299.
10. [10] Dalrymple-Alford, J.C., MacAskill, M.R., Nakas, C.T., Livingston, L., Graham, C., Crucian, G.P., Melzer, T.R., Kirwan, J., Keenan, R., Wells, S., Porter, R.J., Watts, R., Anderson, T.J., The MoCA well-suited screen for cognitive impairment in Parkinson disease. Neurology 75:19 (2010), 1717–1725 (November 9).
11. [11] Nasreddine, Z.S., Phillips, N.A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J.L., Chertkow, H., The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53:4 (2005 Apr), 695–699.
12. [12] Rossetti, H.C., Lacritz, L.H., Cullum, C.M., Weiner, M.F., Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 77:21 (2011), 1272–1275.
13. [13] Lixiu, Zhang, Xueqin, Liu, Determination of the cut-off point of the Chinese version of the montreal cognitive assessment among chinese eldefly in guangzhou. Chin. Ment. Health J., 125, 2008, 151.
14. [14] Lu, J., Li, D., Li, F., Zhou, A., Wang, F., Zuo, X., Jia, X.F., Song, H., Jia, J., Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study. J. Geriatr. Psychiatry Neurol. 24:December (4) (2011), 184–190.
15. [15] Hughes, A.J., Daniel, S.E., Kilford, L., Lees, A.J., Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55:March (3) (1992), 181–184.
16. [16] United Parkinson's Disease Rating Scale (UPDRS version 3.0), Chin. J. Geriatr. (1999) 18 (1) 61–62 (in Chinese).
17. [17] Yuhua, T., Mingyuan, Z., Hamilton depression scale (HAMD). Shanghai Psychiatry 02 (1984), 61–64 (in Chinese).
18. [18] Yuhua, T., Mingyuan, Z., Hamilton anxiety scale (HAMA). Shanghai Psychiatry 02 (1984), 64–65 (in Chinese).
19. [19] Aarsland, D., Andersen, K., Larsen, J.P., et al. The rate of cognitive decline in Parkinson disease. Arch. Neurol. 61 (2004), 1906–1911.
20. [20] Aarsland, D., Muniz, G., Matthews, F., Nonlinear decline of mini-mental state examination in Parkinson's disease. Mov. Disord. 26 (2011), 334–337.
21. [21] Nie, K., Zhang, Y., Wang, L., Zhao, J., Huang, Z., Gan, R., Li, S., Wang, L., A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China. J. Clin. Neurosci. 19:November (11) (2012), 1497–1500.
22. [22] Damian, A.M., Jacobson, S.A., Hentz, J.G., Belden, C.M., Shill, H.A., Sabbagh, M.N., Caviness, J.N., Adler, C.H., The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement. Geriatr. Cogn. Disord. 31:2 (2011), 126–131.
23. [23] Svenningsson, P., Westman, E., Ballard, C., Aarsland, D., Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 11:8 (2012 Aug), 697–707.
24. [24] Janvin, C.C., Larsen, J.P., Aarsland, D., Hugdahl, K., Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov. Disord. 21:September (9) (2006), 1343–1349.
25. [25] Evans, J.R., Mason, S.L., Williams-Gray, C.H., et al. The natural history of treated Parkinson's disease in an incident, community based cohort. J. Neurol. Neurosurg. Psychiatry 82 (2011), 1112–1118.
26. [26] Rajput, A.H., Pahwa, R., Pahwa, P., Rajput, A., Prognostic significance of the onset mode in parkinsonism. Neurology 43:4 (1993 Apr), 829–830.
27. [27] Selikhova, M., Williams, D.R., Kempster, P.A., Holton, J.L., Revesz, T., Lees, A.J., A clinico-pathological study of subtypes in Parkinson's disease. Brain. Nov 132 (2009), 2947–2957 (Pt 11).
28. [28] Klepac, N., Trkulja, V., Relja, M., Nondemented Parkinson disease patients is cognitive performance associated with depressive difficulties?. Cogn Behav. Neurol. 21:June (2) (2008), 87–91.
29. [29] Fernandez, H.H., See, R.H., Gary, M.F., Bowers, D., Rodriguez, R.L., 4th, Jacobson C., Okun, M.S., Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance. J. Geriatr. Psychiatry Neurol. 22:December (4) (2009), 223–227.
30. [30] Meyer, P.M., Strecker, K., Kendziorra, K., Becker, G., Hesse, S., Woelpl, D., Hensel, A., Patt, M., Sorger, D., Wegner, F., Lobsien, D., Barthel, H., Brust, P., Gertz, H.J., Sabri, O., Schwarz, J., Reduced alpha4beta2*- nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch. Gen. Psychiatry 66:8 (2009 Aug), 866–877.